The Recall Desk
ModerateFDA (Drugs)·D-1741-2019·Announced 2019-08-21

US Pharmaceuticals Recalls CRYO-273 Cold Pain Gel Due to Water Quality Issues

US Pharmaceuticals is recalling CRYO-273 Cold Pain Relieving Gel because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that may cause temporary or medically reversible health consequences. The hazard is a manufacturing deviation (water quality) without reported illnesses, fitting the Moderate category for low-risk contamination or voluntary precautionary recalls.

Plain-English summary

US Pharmaceuticals Inc. is recalling 314 cases of CRYO-273 Cold Pain Relieving Gel, 128 FL. OZ. The product was distributed nationwide in the USA by CRYO-273.com in Tampa, FL. The recall involves specific lots with expiration dates ranging from August 2019 to June 2020.

The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the purified water utilized in the manufacturing process produced out-of-specification results for either total microbial count or total organic carbon. These quality control failures indicate that the water used to make the gel did not meet required safety and purity standards.

Consumers who have purchased this product should check their lot numbers and expiration dates against the recalled list. If the product matches the recalled lots, consumers should stop using it and contact the distributor or manufacturer for instructions on return or disposal.

The recalled product

Product
CRYO-273 Cold Pain Relieving Gel 128 FL. OZ. Distributed By: CRYO-273.com Tampa, FL 33629. UPC 8 15290 01550 2
Affected units
314

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot #'s 13K17 EXP 08/2019
  • 03L17 EXP 09/2019
  • 74H18 EXP 06/2020
  • 18J18 EXP 06/2020

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 18 recalled by US Pharmaceuticals Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 18 products in this recall →